iSpecimen Inc.
iSpecimen Inc. (ISPC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ispc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for iSpecimen Inc. (ISPC) measures how much investors pay for each dollar of the company's trailing earnings. ISPC's current PE ratio of N/A is calculated by dividing its stock price of $2.95 by its TTM earnings per share of -$3253.55.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
iSpecimen Inc.You ISPC | $0M | N/A | — | -$3253.55 |
 bioAffinity Technologies, Inc. BIAF | $7M | N/A | — | -$8.66 |
 BioVie Inc. BIVI | $13M | N/A | — | -$11.87 |
 Bluejay Diagnostics, Inc. BJDX | $2M | N/A | — | -$15.25 |
 Galmed Pharmaceuticals Ltd. GLMD | $3M | N/A | — | -$2.39 |
 HeartSciences Inc. HSCS | $4M | N/A | — | -$9.34 |
 ENDRA Life Sciences Inc. NDRA | $3M | N/A | — | -$8.93 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-91.15 | — | |
2024-12-31 FY2024 | — | $-703.27 | — | |
2023-12-31 FY2023 | — | $-982.08 | — | |
2022-12-31 FY2022 | — | $-927.99 | — | |
2021-12-31 FY2021 | — | $-877.23 | — | |
2020-12-31 FY2020 | — | $-3976.14 | — | |
2019-12-31 FY2019 | — | $-4040.21 | — | |
2018-12-31 FY2018 | — | $-4566.23 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for iSpecimen Inc. (ISPC) measures how much investors pay for each dollar of the company's trailing earnings. ISPC's current PE ratio of N/A is calculated by dividing its stock price of $2.95 by its TTM earnings per share of -$3253.55.
Frequently asked questions
ISPC pe ratio · 6 questionsISPC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.95 and TTM EPS of -$3253.55. Data sourced from Financial Modeling Prep via ISPC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · iSpecimen Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09